← Back to Search

COVID-19 Testing for Coronavirus Pandemic

N/A
Waitlist Available
Led By Elizabeth Lynch, PhD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• All individuals who request a COVID-19 test, including pregnant women and children of all ages
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months after end of study
Awards & highlights

Study Summary

This trial is testing a new way to get people in a high-risk, underserved community to get COVID-19 tests.

Eligible Conditions
  • Coronavirus Pandemic

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months after end of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months after end of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COVID-19 Testing Uptake
Other outcome measures
Needs Assessment
Re-AIM Framework

Trial Design

1Treatment groups
Experimental Treatment
Group I: COVID-19 TestingExperimental Treatment1 Intervention
COVID-19 antigen and PCR Testing
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Testing
2021
N/A
~14810

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
153,531 Total Patients Enrolled
Elizabeth Lynch, PhDPrincipal InvestigatorRush University Medical Center
1 Previous Clinical Trials
211 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Illinois
What portion of applicants met pre-screening criteria?
Met criteria
~2500 spots leftby Apr 2025